SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001401914-19-000023
Filing Date
2019-04-09
Accepted
2019-04-09 08:50:06
Documents
4
Period of Report
2019-04-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8-krothuwoffering_2019apr.htm 8-K 30626
2 EXHIBIT 1.1 ex11dare-underwritingagree.htm EX-1.1 223524
3 EXHIBIT 5.1 ex51opinion-rothuwxapril20.htm EX-5.1 9085
4 EXHIBIT 99.1 ex991pressrelease-04072019.htm EX-99.1 11286
  Complete submission text file 0001401914-19-000023.txt   275877
Mailing Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122
Business Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122 858-926-7655
Dare Bioscience, Inc. (Filer) CIK: 0001401914 (see all company filings)

IRS No.: 204139823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36395 | Film No.: 19738536
SIC: 2834 Pharmaceutical Preparations